We sought to evaluate the behavior of cardiac mechanical synchrony as measured by phase SD (PSD) derived from gated MPI SPECT (gSPECT) in patients with super-response after CRT and to evaluate the clinical and imaging characteristics associated with super-response.
158 subjects were evaluated with gSPECT before and 6 months after CRT. Patients with an improvement of LVEF > 15% and NYHA class I/II or reduction in LV end-systolic volume > 30% and NYHA class I/II were labeled as super-responders (SR).
34 patients were classified as super-responders (22%) and had lower PSD (32° ± 17°) at 6 months after CRT compared to responders (45° ± 24°) and non-responders 46° ± 28° (P = .02 for both comparisons). Regression analysis identified predictors independently associated with super-response to CRT: absence of previous history of CAD (odds ratio 18.7; P = .002), absence of diabetes mellitus (odds ratio 13; P = .03), and history of hypertension (odds ratio .2; P = .01).
LV dyssynchrony after CRT implantation, but not at baseline, was significantly better among super-responders compared to non-super-responders. The absence of diabetes, absence of CAD, and history of hypertension were independently associated with super-response after CRT.
Clinical and gated SPECT MPI parameters associated with super-response to cardiac resynchronization therapy.
![Clinical and gated SPECT MPI parameters associated with super-response to cardiac resynchronization therapy.](https://cdn.physiciansweekly.com/wp-content/uploads/2022/09/Hand-touching-on-protection-treatment-prevention-and-patronage-health-icon-with-internal-organs-heart-brain-kindneys-liver-lungs-stomach.-st-e1723147186703-1280x640.jpg)
Create Post
Twitter/X Preview
Logout